JP Morgan Maintains Neutral on ArcBest, Raises Price Target to $87

Benzinga · 10/08/2025 17:28
JP Morgan analyst Brian Ossenbeck maintains ArcBest (NASDAQ:ARCB) with a Neutral and raises the price target from $85 to $87.